Price $5.80 |
Market Cap
352M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
16.1
|
P/B
1.43
|
P/S
4.29
|
Dividend %
-
|
|
P/CF
3.0
|
P/FCF
10.8
|
Op. Cash Flow
35K
|
FCF
0.4
|
|
Op. Margin
27.00%
|
Net Margin
30.00%
|
ROE
13.70%
|
ROI
-27.80%
|
|
ROA
11.70%
|
EPS Growth
163.40%
|
Current Ratio
14.7
|
Debt/Equity
0.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $8.79 | - | - | 110.8M | Strong Buy |
| Dyadic International, Inc. (DYAI) | $6.24 | - | - | 120.1M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $3.00 | - | - | 202.9M | Strong Buy |
| Celexus Inc (CXUS) | $1.35 | - | - | 5.2M | Strong Buy |
| DURECT Corporation (DRRX) | $0.51 | - | - | 86M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
